Weightloss Medication Options
Tirzepatide
Tirzepatide has been clinically proven to help patients achieve up to ≥25% weight loss, making it one of the most effective weight management solutions available today.
What is Tirzepatide?
The active ingredient in Mounjaro, originally approved for treating type 2 diabetes, has shown incredible weight loss benefits, leading to its off-label use for chronic weight management. This success prompted the development of Zepbound, which was approved in 2023 specifically for chronic weight management.

How It Works
Tirzepatide mimics the action of the body’s natural GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic polypeptide). These hormones signal the pancreas to increase insulin production, which helps lower blood sugar levels. As a dual GLP-1 and GIP receptor agonist, Tirzepatide targets multiple pathways in the body to enhance weight loss.
In simple terms:
-
Makes you feel less hungry
-
Makes you feel full faster
-
Helps you lose weight
-
Better manages blood sugar control​​​
Choose Your Tirzepatide Plan
Achieve transformative weight loss with affordable Tirzepatide bundles tailored to fit your health goals and budget. Each plan offers personalized care, custom titration, and expert support to ensure long-term success.
What Included:
-
Weekly Tirzepatide injections customized to your unique needs and goals.
-
Comprehensive provider evaluation and personalized titration plan.
-
Close monitoring to track progress and ensure safety.
-
Direct provider support for specialist guidance.
-
Convenient delivery of medication right to your door or In-Clinic access to care.
-
Sustainable weight loss guidance to support long-term results.
​
Did You Know?
This program costs less than a daily coffee shop splurge—and delivers life-changing results.
Available by prescription only after an online healthcare evaluation. Benefits are based on third-party research. Physicians may prescribe compounded medications to address patient-specific needs or shortages. Actual packaging may vary. The FDA does not review compounded medications for safety or effectiveness. Compounded tirzepatide is not FDA-approved for weight loss, though studies suggest potential benefits. Individual results may vary.​​

